SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008798
Filing Date
2018-11-07
Accepted
2018-11-07 16:18:21
Documents
56
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q osir-20180930x10q.htm 10-Q 1216266
2 EX-31.1 osir-20180930ex3116cec76.htm EX-31.1 16394
3 EX-31.2 osir-20180930ex312adf77a.htm EX-31.2 16489
4 EX-32.1 osir-20180930ex321bacb76.htm EX-32.1 11931
  Complete submission text file 0001558370-18-008798.txt   5101647

Data Files

Seq Description Document Type Size
5 EX-101.INS osir-20180930.xml EX-101.INS 1257683
6 EX-101.SCH osir-20180930.xsd EX-101.SCH 30464
7 EX-101.CAL osir-20180930_cal.xml EX-101.CAL 49621
8 EX-101.DEF osir-20180930_def.xml EX-101.DEF 76773
9 EX-101.LAB osir-20180930_lab.xml EX-101.LAB 300693
10 EX-101.PRE osir-20180930_pre.xml EX-101.PRE 204804
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 181166589
SIC: 2836 Biological Products, (No Diagnostic Substances)